OpenVSafe by OpenVAERS
Search V-safe

456-42577-77056

1 vaccination 3 coded responses 12 check-ins 3 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
927 / CA
Registered
2021-11-09
Relationship
Child or adolescent in my care
Guardian
4GN-30899-56233
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-09
    Registered in v-safe
  2. 2021-11-09
    Dose 1 — Pfizer-BioNTech
  3. 2021-11-09
    Health check-in — day 0, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-11-10
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site
    Adult check-in
  5. 2021-11-11
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  6. 2021-11-12
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-11-13
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-11-14
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: Good
    Free text: Mild congestion and stuffy nose, possibly due to a developing head cold or allergies.
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-11-15
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Cough, Respiratory tract congestion — Feeling: Good
    Free text: Cough and mild congestion, possibly a mild head cold or allergies (not suspected to be COVID-19).
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-11-16
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-11-23
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  12. 2021-11-30
    Health check-in — day 21, dose 1, dependent
    Feeling: Good
    Adult check-in
  13. 2022-02-08
  14. 2022-05-10
    Survey response — 6 months, dose 1, dependent
    MedDRA: Influenza, Nasopharyngitis, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Upper respiratory infection (flu/cold virus)
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-09Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 1, dependent

2021-11-14

Systemic reaction (other): Mild congestion and stuffy nose, possibly due to a developing head cold or allergies.

2021-11-15

Systemic reaction (other): Cough and mild congestion, possibly a mild head cold or allergies (not suspected to be COVID-19).

Release 11 — 6 months, dose 1, dependent

2022-05-10

Symptoms: Upper respiratory infection (flu/cold virus)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDInfluenza · · ✓
SDNasopharyngitis · · ✓
SDUpper respiratory tract infection · · ✓
SROCough · · ✓
SRONasal congestion · · ✓
SRORespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release